The University of Oxford and the Serum Institute of India (SII) have started the world's first human trial of a vaccine ...
The Print on MSN
Century after last TB vaccine, India’s Serum Institute partners with Gates MRI for novel jab
Tuberculosis remains world’s deadliest infectious disease despite being preventable and curable. Around 1.23 million of 10.7 ...
Pune: The Serum Institute of India (SII) has dispatched 4,000 investigational doses of a newly manufactured Ebola vaccine ...
India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under ...
Serum Institute of India has partnered with Gates Medical Research Institute to manufacture M72/AS01E, a tuberculosis vaccine ...
Serum Institute will invest over US$100 million to manufacture the M72/AS01E vaccine if approved, a breakthrough that could become the world's first new tuberculosis vaccine in more than a century. In ...
The Serum Institute of India has supplied 4,000 investigational doses for the Phase I study.
A new TB vaccine could be the biggest breakthrough in over 100 years. The Serum Institute of India (SII) will manufacture the ...
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on. Benchmark your ...
Watch videos, top stories and articles on Serum Institute Of India (sii) at moneycontrol.com.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results